Drug Policy in Slovakia

Slides:



Advertisements
Similar presentations
Health Benefits of Nordic Walking
Advertisements

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Performance Assessment of the Juaboso District Office of the National Health Insurance Authority  Paul Effah, MBA, Kingsley Opoku Appiah, PhD, FCCA, Patience.
Geography of Adolescent Obesity in the U.S., 2007−2011
Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective.
Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia  Juan-Carlos Castro, MD,
Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis  Klára Kruntorádová, MSc, Jiří Klimeš,
Self-regulation in a small professional group is an important step toward professionalization: the Chiropractic Association in Singapore  Anna Maria S.
Value and Service Quality Assessment of the National Health Insurance Scheme in Ghana: Evidence from Ashiedu Keteke District  Eric Nsiah-Boateng, MSc,
Value in Health Regional Issues
Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece: Focusing on Price Reductions and Cost-Sharing Rates  Siskou Ch. Olga,
Value in Health Regional Issues
Eric Nsiah-Boateng, MPH, Moses Aikins, PhD 
Value and Service Quality Assessment of the National Health Insurance Scheme in Ghana: Evidence from Ashiedu Keteke District  Eric Nsiah-Boateng, MSc,
An Audit of Diabetes-Dependent Quality of Life (ADDQOL) in Older Patients with Diabetes Mellitus Type 2 in Slovenia  Eva Turk, MA, MBA, Valentina Prevolnik.
S. Kılınç, C. Campbell  Seizure - European Journal of Epilepsy 
The Development of the Romanian Scorecard HTA System
Urine Drug Screening: Practical Guide for Clinicians
Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary  András Inotai, PharmD, PhD, Zsolt Abonyi-Tóth, MSc, György.
Value in Health Regional Issues
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt
From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand,
Impact of the Pharma Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)  Rok Hren, PhD,
Systematic Review of Economic Evaluation Literature in Ghana: Is Health Technology Assessment the Future?  Emmanuel Ankrah Odame, MBCHB, MPH  Value in.
Drug Policy in Croatia Value in Health Regional Issues
Prevalence, Awareness, Treatment, and Burden of Major Depressive Disorder: Estimates from the National Health and Wellness Survey in Brazil  Ronaldo K.
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs)
The Process of Privatization of Health Care Provision in Poland
Ernest Attuquaye Quaye, BPharm, MPH, Edward O
The Living with Medicines Questionnaire: Translation and Cultural Adaptation into the Arabic Context  Amani Zidan, BScPharm, Ahmed Awaisu, PhD, Sanah.
Drug Policy in Bulgaria
Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis  Klára Kruntorádová, MSc, Jiří Klimeš,
Patterns of Care and Treatment Target Success among Persons with Type 2 Diabetes Mellitus in Dubai: A Retrospective Cohort Study  Katherine M. Osenenko,
Value in Health Regional Issues
Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective.
Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary  Zoltán Kaló, MSc, MD, PhD, József Bodrogi, MSc, Imre Boncz,
Rutger Daems, PhD, Edith Maes, DBA, Christoph Glaetzer, Dipl, Kfm 
Cost-Benefit Analysis and Assessment of Quality of Care in patients with Hemophilia undergoing treatment at National Rural Health Mission in Maharashtra,
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore  Vivianne Shih, PharmD, BCOP, BCPS, Alexandre Chan, PharmD,
What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?” Critical Issues of Assessment.
Assessment of Adverse Events and Quality of Life of Cancer Patients in a Secondary Level Care, Rural Hospital in South India  S.K.R. Sowmya, PharmD, Dixon.
Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems  Randall Winnette, MSc, Victor Zárate, MD, MSc,
Classified Advertising
Advancing the Visibility, Impact, and Quality Metrics of Value in Health Regional Issues  Dan Greenberg, PhD, Imre Boncz, MD, MSc, PhD, Habil, Ahmed Awaisu,
Omneya Mohamed, PhD, David H. Kreling, PhD 
A New Framework for Addressing Adverse Childhood and Community Experiences: The Building Community Resilience Model  Wendy R. Ellis, DrPH (c), MPH, William.
Drug Policy in the Czech Republic
Highlights From the Third Annual Mayo Clinic Conference on Systems Engineering and Operations Research in Health Care  Janine R.A. Kamath, MBA, MA, John.
A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations  Panagiotis Petrou, MBA, PhD, PhDc, Michalis.
Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary  András Inotai, PharmD, PhD, Zsolt Abonyi-Tóth, MSc, György.
Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project  Kyriakos Souliotis, PhD,
Translational Behavioral Research in Respiratory Medicine
Cost-Effectiveness Analysis Expands its Reach Worldwide
Guidance Document: Global Pharmacoeconomic Model Adaption Strategies
Jing Wu, PhD, Ning Yue, MS, Weiwei Xu, PhD 
HTA and Its Use in Drug Policies: Singapore
Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea  Ji Haeng Heo, MS, Karen L.
Dossier System as a Practical Tool for Compiling Reimbursement Lists
Colombian Health System on its Way to Improve Allocation Efficiency—Transition from a Health Sector Reform to the Settlement of an HTA Agency  Nicolás.
Value in Health Regional Issues
Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not.
Performance Assessment of the Juaboso District Office of the National Health Insurance Authority  Paul Effah, MBA, Kingsley Opoku Appiah, PhD, FCCA, Patience.
The Drug Reimbursement Decision-Making System in Iran
Social Cost of Substance Abuse in Russia
Organization news Archives of Physical Medicine and Rehabilitation
Economic Evaluation of Four Drug Administration Systems in Intensive Care Units in Colombia  Diego Rosselli, MD, MSc, Juan David Rueda, MD, María Daniela.
Victoria I. Ignatyeva, MPH, Johan L
Drug Policy in Hungary Value in Health Regional Issues
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Presentation transcript:

Drug Policy in Slovakia Maria Bucek Psenkova, RNDr, MPH, Martin Visnansky, PharmD, MBA, MSc(HTA), PhD, Stanislava Mackovicova, Ing, Dominik Tomek, PharmD, PhD, MPH, MSc  Value in Health Regional Issues  Volume 13, Pages 44-49 (September 2017) DOI: 10.1016/j.vhri.2017.07.002 Copyright © 2017 Terms and Conditions

Figure 1 The decision making process for setting the price and reimbursement of new drugs. SIDC - The State Institute for Drug Control; EMA – European Medicines Agency; P&R – Price and Reimbursement; HTA – Health Technology Assessment; ATC – Anatomic and Therapeutic Classification; MoH – Ministry of Health. Value in Health Regional Issues 2017 13, 44-49DOI: (10.1016/j.vhri.2017.07.002) Copyright © 2017 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.